首页> 美国卫生研究院文献>Clinical Practice and Cases in Emergency Medicine >Central Venous Catheter-directed Tissue Plasminogen Activator in Massive Pulmonary Embolism
【2h】

Central Venous Catheter-directed Tissue Plasminogen Activator in Massive Pulmonary Embolism

机译:中央静脉导管定向组织纤溶酶原激活物在大规模肺栓塞中的作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We present the case of an 88-year-old female who presented to the emergency department (ED) with suspected massive pulmonary embolism (PE) causing respiratory failure, right heart strain, and shock, who despite early and aggressive resuscitation with vasopressors and continuous peripheral infusion of tissue plasminogen activator (tPA), suffered a cardiac arrest in the ED. We describe the approach of a tPA bolus directed through a central venous catheter, resulting in return of spontaneous circulation and immediate improvement in physiologic parameters prior to confirmation of PE with computed tomography angiogram. We further hypothesize that in patients deemed too unstable to be transferred for embolectomy or catheter-directed thrombolysis, central venous catheter-directed bolus tPA may be more effective than peripheral infusion alone.
机译:我们提供了一个88岁的女性病例,该女性因出现严重的肺栓塞(PE)导致呼吸衰竭,右心劳损和休克而被送往急诊科(ED),尽管她已通过血管加压药进行了早期和积极的复苏并持续外周输注组织纤溶酶原激活剂(tPA),导致ED发生心脏骤停。我们描述了通过中央静脉导管定向tPA推注的方法,导致自发循环的恢复和生理参数的立即改善,然后通过计算机断层扫描血管造影术确认PE。我们进一步假设在认为因不稳定而无法进行栓塞切除术或导管定向溶栓的患者中,中心静脉导管定向推注tPA可能比单独的外周输注更为有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号